Literature DB >> 24453753

Differentiation of neuromyelitis optica from multiple sclerosis on spinal magnetic resonance imaging.

Saurabh Lalan1, Majid Khan1, Bruce Schlakman1, Alan Penman1, Joseph Gatlin1, Robert Herndon1.   

Abstract

In order to examine the accuracy of magnetic resonance imaging (MRI)-based diagnosis of neuromyelitis optica (NMO) versus multiple sclerosis (MS), we performed a retrospective, rater-blinded review of 29 cases of NMO and 30 cases of MS using the criteria of long (more than three vertebral levels), continuous lesions with a central cord location for NMO and more peripheral and patchy lesions for MS. Using these criteria, two raters were able to distinguish the two conditions with a good degree of confidence, particularly when the imaging was performed at the time of an acute cord attack. The sensitivity and specificity for diagnosis of NMO were 86.2% and 93.3%, respectively, for Rater A and 96.4% and 78.6%, respectively, for Rater B, with a kappa value of 0.72. Thus there are significant differences in lesion characteristics that allow the distinction on spinal cord imaging between MS and NMO with a moderately high degree of confidence. The location of the lesion as evident on MRI of the spine can be regarded as a distinguishing diagnostic feature between MS and NMO.

Entities:  

Year:  2012        PMID: 24453753      PMCID: PMC3882989          DOI: 10.7224/1537-2073-14.4.209

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  14 in total

1.  The clinical course of neuromyelitis optica (Devic's syndrome).

Authors:  D M Wingerchuk; W F Hogancamp; P C O'Brien; B G Weinshenker
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

Review 2.  Neuromyelitis optica: current concepts.

Authors:  Dean M Wingerchuk
Journal:  Front Biosci       Date:  2004-01-01

3.  Have we finally identified an autoimmune demyelinating disease?

Authors:  Moses Rodriguez
Journal:  Ann Neurol       Date:  2009-11       Impact factor: 10.422

4.  Clinical, CSF, and MRI findings in Devic's neuromyelitis optica.

Authors:  J I O'Riordan; H L Gallagher; A J Thompson; R S Howard; D P Kingsley; E J Thompson; W I McDonald; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

5.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

6.  Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination.

Authors:  Yoko Warabi; Yoh Matsumoto; Hideaki Hayashi
Journal:  J Neurol Sci       Date:  2006-11-27       Impact factor: 3.181

7.  Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

Authors:  R N Mandler; L E Davis; D R Jeffery; M Kornfeld
Journal:  Ann Neurol       Date:  1993-08       Impact factor: 10.422

8.  Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution.

Authors:  Elisa Bizzoco; Francesco Lolli; Anna Maria Repice; Bahia Hakiki; Mario Falcini; Alessandro Barilaro; Rosanna Taiuti; Gianfranco Siracusa; Maria Pia Amato; Tiziana Biagioli; Silvia Lori; Marco Moretti; Annalisa Vinattieri; Patrizia Nencini; Luca Massacesi; Sabrina Matà
Journal:  J Neurol       Date:  2009-05-28       Impact factor: 4.849

Review 9.  Neuromyelitis optica.

Authors:  Bruce A C Cree; Douglas S Goodin; Stephen L Hauser
Journal:  Semin Neurol       Date:  2002-06       Impact factor: 3.420

10.  Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.

Authors:  Friedemann Paul; Sven Jarius; Orhan Aktas; Martin Bluthner; Oliver Bauer; Heribert Appelhans; Diego Franciotta; Roberto Bergamaschi; Edward Littleton; Jacqueline Palace; Hans-Peter Seelig; Reinhard Hohlfeld; Angela Vincent; Frauke Zipp
Journal:  PLoS Med       Date:  2007-04       Impact factor: 11.069

View more
  6 in total

1.  CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.

Authors:  Ding Chen; Sara J Ireland; Gina Remington; Enrique Alvarez; Michael K Racke; Benjamin Greenberg; Elliot M Frohman; Nancy L Monson
Journal:  J Immunol       Date:  2016-10-26       Impact factor: 5.422

Review 2.  Magnetic resonance imaging in neuromyelitis optica spectrum disorder.

Authors:  Laura Clarke; Simon Arnett; Kate Lilley; Jacky Liao; Sandeep Bhuta; Simon A Broadley
Journal:  Clin Exp Immunol       Date:  2021-07-06       Impact factor: 4.330

3.  Detection of Antibodies against Human and Plant Aquaporins in Patients with Multiple Sclerosis.

Authors:  Aristo Vojdani; Partha Sarathi Mukherjee; Joshua Berookhim; Datis Kharrazian
Journal:  Autoimmune Dis       Date:  2015-07-26

4.  Reduction in circulating vitamin D binding protein in patients with multiple sclerosis.

Authors:  Zhila Maghbooli; Abolfazl Omidifar; Tarlan Varzandi; Tayebeh Salehnezhad; Mohammad Ali Sahraian
Journal:  BMC Neurol       Date:  2021-04-20       Impact factor: 2.474

Review 5.  A Comprehensive Review on the Role of Genetic Factors in Neuromyelitis Optica Spectrum Disorder.

Authors:  Soudeh Ghafouri-Fard; Tahereh Azimi; Mohammad Taheri
Journal:  Front Immunol       Date:  2021-10-05       Impact factor: 7.561

6.  Rare variants and HLA haplotypes associated in patients with neuromyelitis optica spectrum disorders.

Authors:  Inna Tabansky; Akemi J Tanaka; Jiayao Wang; Guanglan Zhang; Irena Dujmovic; Simone Mader; Venkatesh Jeganathan; Tracey DeAngelis; Michael Funaro; Asaff Harel; Mark Messina; Maya Shabbir; Vishaan Nursey; William DeGouvia; Micheline Laurent; Karen Blitz; Peter Jindra; Mark Gudesblatt; Alejandra King; Jelena Drulovic; Edmond Yunis; Vladimir Brusic; Yufeng Shen; Derin B Keskin; Souhel Najjar; Joel N H Stern
Journal:  Front Immunol       Date:  2022-10-04       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.